Wei He

Title: Innovations of Wei He in Cancer Immunotherapy

Introduction

Wei He is an accomplished inventor based in San Diego, CA. He has made significant contributions to the field of cancer immunotherapy, holding a total of 3 patents. His work focuses on innovative approaches to enhance cancer treatment through the use of arginine depletion agents.

Latest Patents

Wei He's latest patents include groundbreaking research on combination cancer immunotherapies with arginine depletion agents. This patent provides arginine depletion agents, such as ADI-PEG, for use in conjunction with cancer immunotherapies, including immune checkpoint modulators and T-cell adoptive immunotherapies, aimed at treating various cancers. Another notable patent involves engineered chimeric pegylated ADI and methods of use, which details chimeric arginine deiminases, including pegylated variants, and their applications in cancer treatment.

Career Highlights

Throughout his career, Wei He has worked with notable companies such as Tdw Group and Polaris Group. His expertise in the field has allowed him to develop innovative solutions that address critical challenges in cancer therapy.

Collaborations

Wei He has collaborated with esteemed colleagues, including Bor-Wen Wu and Yunyun Guo, to advance research and development in cancer immunotherapy.

Conclusion

Wei He's contributions to cancer immunotherapy through his patents and collaborations highlight his commitment to improving treatment options for patients. His innovative approaches continue to pave the way for advancements in the field.